Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors
-
* Corresponding author: Keizo Kanasaki kkanasak@kanazawa-med.ac.jp
Fibrogenesis & Tissue Repair 2011, 4:25 doi:10.1186/1755-1536-4-25
Accesses
- Last 30 days: 116 accesses
- Last 365 days: 923 accesses
- All time: 923 accesses